144 related articles for article (PubMed ID: 31876619)
1. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers.
Ruan X; Cai G; Wei Y; Gu M; Zhang Y; Zhao Y; Mueck AO
Menopause; 2020 Feb; 27(2):183-193. PubMed ID: 31876619
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics.
Cai G; Yang X; Ruan X; Wang J; Fang Y; Wei Y; Zhang Y; Gu M; Mueck AO
Maturitas; 2020 Oct; 140():64-71. PubMed ID: 32972637
[TBL] [Abstract][Full Text] [Related]
3. The association of five preoperative serum tumor markers and pathological features in patients with breast cancer.
Lian M; Zhang C; Zhang D; Chen P; Yang H; Yang Y; Chen S; Hong G
J Clin Lab Anal; 2019 Jun; 33(5):e22875. PubMed ID: 30843272
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract][Full Text] [Related]
5. May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?
Zhang Y; Ruan X; Willibald M; Seeger H; Fehm T; Neubauer H; Mueck AO
Gynecol Endocrinol; 2016; 32(1):58-60. PubMed ID: 26303031
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.
Causey MW; Huston LJ; Harold DM; Charaba CJ; Ippolito DL; Hoffer ZS; Brown TA; Stallings JD
J Surg Res; 2011 Dec; 171(2):615-22. PubMed ID: 20655063
[TBL] [Abstract][Full Text] [Related]
7. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
8. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
[TBL] [Abstract][Full Text] [Related]
9. PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study.
Cai G; Ruan X; Gu M; Zhao Y; Wang Y; Mueck AO
Gynecol Endocrinol; 2020 Nov; 36(11):1024-1027. PubMed ID: 32208774
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer.
Ruan X; Zhang Y; Mueck AO; Willibald M; Seeger H; Fehm T; Brucker S; Neubauer H
Menopause; 2017 Feb; 24(2):203-209. PubMed ID: 27749742
[TBL] [Abstract][Full Text] [Related]
11. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
13. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
16. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Yang Q; Zhang P; Wu R; Lu K; Zhou H
Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
18. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
19. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
